Evidence map›Paper›PMID 39665983›Full record

ArticleNaunyn-Schmiedeberg's archives of pharmacology2025

Synthesis of platinum nanoparticles functionalized with glutamine and conjugated with thiosemicarbazone and their cytotoxic effects on MDA-MB-231 breast cancer cell line and evaluation of CASP-8 gene expression.

Nabeel Rahi Mashkoor, Salwan Ali Abed, Arash Davoudi, Zahraa Aqeel Adel Jassim, Zainab Yousif Faraj, Fatemeh Akbari, Fahimeh Abedini Bajgiran, Mohammad Hedayati, Ali Salehzadeh

Abstract read
PubMed Publisher
In one paragraph

Article in Naunyn-Schmiedeberg's archives of pharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Nabeel Rahi MashkoorDepartment of Pathological Analysis, College of Science, AL-Qadisiyah University, Al Diwaniyah, AL-Qadisiyah, Iraq.
Salwan Ali AbedEnvironmental Science Department, College of Science, AL-Qadisiyah University, Al Diwaniyah, AL-Qadisiyah, Iraq.
Arash DavoudiDivision of Cytogenetic, Dr. Keshavarz Medical Genetics Lab, Rasht, Iran.
Zahraa Aqeel Adel JassimScientific Affairs Department, AL-Qadisiyah University, Al Diwaniyah, AL-Qadisiyah, Iraq.
Zainab Yousif FarajScientific Affairs Department, AL-Qadisiyah University, Al Diwaniyah, AL-Qadisiyah, Iraq.
Fatemeh AkbariDepartment of Biology, Faculty of Basic Sciences, Shahrekord Branch, Islamic Azad University, Shahrekord, Iran.
Fahimeh Abedini BajgiranDepartment of Biology, Rasht Branch, Islamic Azad University, Rasht, Iran.
Mohammad HedayatiGuilan University of Medical Sciences, Rasht, Iran.
Ali SalehzadehDepartment of Biology, Rasht Branch, Islamic Azad University, Rasht, Iran. a.salehzadeh@iau.ac.ir.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Breast cancer (BC) is the most prevalent form of cancer among women and is a major contributor to cancer-related fatalities. Nanotechnology has provided novel approaches to drug delivery to cancer cells. In this work, we synthesized platinum (Pt) nanoparticles, functionalized them with glutamine, conjugated them with thiosemicarbazone (TSC), and characterized their anticancer effects on the MDA-MB-231 breast cancer cell line. Characteristics of the nanoparticles were assessed by FT-IR, XRD, EDS mapping, SEM, TEM, DLS, and zeta potential measurement. Cell viability was characterized by MTT assay, and cell necrosis/apoptosis levels were determined by flow cytometry. The expression level of the CASP-8 gene was investigated by real-time PCR. Pt@Gln-TSC nanoparticles are spherical, 20-70 nm in diameter in dry form, 662 nm after hydration, and their zeta potential was - 6.6 mV. The 50% inhibitory concentration (IC

Indexed as

Antineoplastic AgentsBreast NeoplasmsCaspase 8GlutamineMetal NanoparticlesPlatinumThiosemicarbazonesApoptosisCell Line, TumorCell SurvivalFemaleGene Expression Regulation, NeoplasticHumansAntineoplastic AgentsCASP8 protein, humanCaspase 8GlutaminePlatinumThiosemicarbazonesApoptosisBreast cancerFlow cytometryPlatinum nanoparticlesThiosemicarbazone

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.